Antithrombotic Therapies for Acute Coronary Syndrome and Atrial Fibrillation
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 20 December 2025 | Viewed by 268
Special Issue Editor
Interests: haemostasis assays; thrombophilia; direct oral anticoagulants
Special Issue Information
Dear Colleagues,
Atrial fibrillation (AF) and acute coronary syndrome (ACS) significantly increase the risk of thromboembolic events. Treatment of these conditions has evolved from vitamin K antagonists and aspirin to novel antithrombotic therapies, reflecting advances in our understanding of the pathophysiology of these conditions. This Special Issue looks at the latest developments in antithrombotic therapy for AF and ACS, highlighting innovative approaches to prevention and treatment as well as the challenges in clinical practice. We are soliciting original research articles, reviews and clinical trials that address the latest advances in antithrombotic therapies for patients with AF and ACS. Our aim is to highlight innovative strategies, evaluate current treatment protocols and identify gaps in knowledge that require further investigation. We encourage submissions that address the efficacy and safety of novel anticoagulants, patient-centred approaches to therapy selection, and the integration of technology in the monitoring and treatment of these conditions.
Dr. Mojca Božič Mijovski
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atrial fibrillation
- acute coronary syndrome
- antiplatelet agents
- anticoagulants
- thrombolysis
- direct coagulation factor inhibitors
- medical laboratory technology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
